1227573-92-3 Usage
Uses
Used in Pharmaceutical Industry:
(3-Methoxy-6-trifluoromethyl-pyridin-2-yl)-methanol is used as a building block for the synthesis of new drugs and pharmaceutical intermediates. Its unique structure and functional groups contribute to the development of innovative therapeutic agents.
Used in Agrochemicals:
In the agrochemical industry, (3-Methoxy-6-trifluoromethyl-pyridin-2-yl)-methanol is used as a precursor for the synthesis of compounds with specific properties, potentially enhancing the effectiveness of agrochemical products.
Used in Materials Science:
(3-Methoxy-6-trifluoromethyl-pyridin-2-yl)-methanol is utilized in materials science for the synthesis of compounds with tailored properties, such as improved stability or specific interactions, which can be applied in various material applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1227573-92-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,5,7 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1227573-92:
(9*1)+(8*2)+(7*2)+(6*7)+(5*5)+(4*7)+(3*3)+(2*9)+(1*2)=163
163 % 10 = 3
So 1227573-92-3 is a valid CAS Registry Number.
1227573-92-3Relevant articles and documents
Triazolopyridazine derivative as well as preparation method, pharmaceutical composition and application thereof
-
, (2021/06/22)
The invention relates to triazolopyridazine derivatives as well as a preparation method, a pharmaceutical composition and application thereof. The invention provides a compound shown in a general formula (I), cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound, and a preparation method of the compound, the cis-trans isomers, the enantiomers, the diastereoisomers, the racemes, the solvates, the hydrates or the pharmaceutically acceptable salts or the prodrugs of the compound; preparation method thereof; pharmaceutical compositions containing the compounds, and the use of the compounds as alpha 5-GABAA receptor modulators, wherein R 1, R 2, and Z are as defined in the specification. pharmaceutical compositions containing the compounds and application of the compounds as alpha-5-GABAA receptor modulators, wherein R1, R2 and Z are as defined in the specification.
